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S tcutlcss valves lmve shown hemodynamic superior- 
it)" with speedy regression of left ventricular hyper- 
trophy and subsequently clmnged surgical practice 
during tim recent years. 1-s An increasing number of 
different models from different manufacturers stress 
the continuing interest in this form of replacement 
devices for aortic valve disease. 
Dev ice  
The Edwards Prima Plus Stentless Bioprothesis (Ed- 
wards Lifescicnce Corp, Irvine, CA) offers a full range 
of steutless valve technolo~' features, inchnling: 
9 Extended full porcine root to nmximize huplant options 
9 Low-pressure fixation of both the root and leaflets to 
produce a combination of strength and tissue flexibil- 
ity while maintaining the natural valve geometry and 
sinus shape 
9 A green trinuning guideline to indicate safe limits of 
tissue trimming for subcoronary implantation 
9 Three marking sutures to aid orientation of the valve 
during implantation 
9 Minimum fabric usage to enhance pliability (Fig- 
ure 1). 
A complete accessory system, inchnling a specially de- 
signed hohlcr, valve handle, and dedicated sizers, is 
also available. 
Patients 
From October 1, 1993 to December 31, 1998, 568 con- 
secutive patients received Edwards Prima stentless aor- 
tic valves at our institution. Included iu this series are 
70 patients in whom the senior author performed im- 
plantation at the University of Muenster/Westfalcn 
from 1991 to 1993. The patients ranged in age from 24 
to 9,1 years, with a median age of 67 years (mean 65 - 
11 yrs), and 42% of the patients were female. Under- 
lying pathology was pure aortic stenosis in 37%, aortic 
regurgitation i 27%, and a mixed lesion in 36%. Na- 
tive or prosthetic valve endocarditis was the indication 
for operation in 19 patients, and 21 had undergone 
previous aortic valve or other cardiac surgery. A total 
of 352 patients received a subcoronary implantation, 
183 received root inclusion cylinder implantation, and 
33 received full root replacement. Concomitant cardiac 
repairs, most often coronary artery bypass grafting, 
mitral valve repair or replacement, or ascending aorta 
replacement, was done in 38% of the patients. 
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SURGICAL TECHNIQUE 
The operat ion is performed under  card iopnlmonary 
bypass with antegrade warm Mood cardioplc~a. Expo- 
sure of the aortic valve can l)e ol)taincd using a trans- 
verse or an ol)lique ("hockey stick") aortotomy. We 
prefer the transverse al)proach, which makes pros- 
thetic valve commissural al ignment easier. After the 
diseased aortic valve is excised and all annular  calcium 
is coml)letely removed, sizing is i)erformed. We use 
either the manufacturer ' s  sizer or graded l)all-shaped 
sizers. The sizing instrument shouhl fit snugly into the 
annulus.  The valve allows for sul)coronary or inclusion 
cyl inder implantat ion as well as for full root replace- 
mcnt,  according to the natnre  of the pathologic process 
involving the native valve, the aortic root, and the 
l)roximal ascending aorta.  
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2 Suture placement and orientation. Siml)le interrupted sutures of either 2-0 
muhifilanlent or 4-0 monofilalnent are l)laced in a horizontal )lane ill the native 
annulus at the level of the lowest commissure. Usually 18 to 22 stitches are needed. 
The valve is oriented such that the corollary ostia of the bioprothesis align with or 
accommodate he coronary ostia of the patient. 
Important: Because of tile 1)resence of tile l)orcine lnuscle shelf under tile right 
coronary ostium, special attention must be paid to the location of tile 1)atient's 
coronary ostium. In patients where the right coronary ostium is close to the aortic 
annulus, modifications of the implant technique should be considered to avoid 
inward fohling of tile cloth-covered muscle shelf into the outflow area. This can be 
accoml)lished by rotating tile valve so that tile woven cloth beneath tile right corollary 
ostium faces the noncoronary sinus (rotated sul)coronary) or by using tile bioproth- 
esis as a root rel)lacemcnt. (Courtesy of Edwards Lifesciences SAS.) 
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Trimming for subcoronary iuiplantation. A green trinuning guideline is 
l,rovidcd externally on the bioprothesis to indicate safe linfits of tissue trimming 
for sul,coronary or modified sul)coronary imi,lantation. The trimming guideline 
is placed a minimuni of 
9 3 mm above the top of each comnfissure 
9 1.5 nun outside of each conmfissure side 
9 1.5 him above the sinus leaflet attachment area 
Tissue nnlst lie trinnned above the greeu triunning guideline to aeeonnnodate tile 
liatient's anatoniy and to avoid eoutact with the leaflet attaclunent area. The 
noncoronary sinus nmy lie left untrinuned. (Courtesy of Edwards Lifesciences 
SAS.) 
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4 Second sutureline. For subcoronary im- 
plantation, the stentless bioprothesis com- 
missures are al i~etl  against the patient's 
aortic wall, with care taken to maintain the 
natural porcine valve geometry. The second 
suture line is performed with a running su- 
ture teclmique using 4/0 monofilament su- 
tures. Starting at the base of the right sinus, 
the left sinus or the commissure between the 
left and the right sinus, the stitches arc ad- 
vanced tinder the right coronary/left coro- 
nary orifices to meet at the noncoronary si- 
nus, where they are tied off. The aortotomy is
closed in a usual manner. 
hnl)ortant: Needle puncture of the valve 
should be avoided. If  tiffs sbouhl haliliell in- 
advertently, the valve shouhl be discarded. 
(Courtesy of Edwards Lifeseiences SAS.) 
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5 Inclusion cylinder iml)lantatiou. To trim the bioprothcsis for an 
inclusion cylinder implantation, the left and right coronary silmses are 
excised. The proximal sutures are placed as for subcoronary implanta- 
tion (see 2). (Courtesy of Edwards Lifescicnces SAS.) 
6 Completion of inclusion cylinder implantation. For inclusion cylinder 
f t  r  implantation, tile lfioi)rothcsis commissures arc ali~ued a~ainst he 1)atient s
aortic wall, with care taken to maintain the natural porcine valve geometry. 
The bioprosthesis  secured to the patient's aortic wall using two 5/0 mouo- 
filament sutures. 
Conveniently, suturing is started at the lowest point. The rim of the excised 
coronary sinus of the prothcsis is attached around the patient's coronary ostia 
to the aortic wall. The surgeon must make sure that the length of the 
lfioprothcsis and the patient's aorta are the same length, to avoid excess aortic 
wall tissue in the lon~tudinal dircction. The aortotomy is closed with a 4-0 
monofilament suture including the bioprothesis and both nmrgins of the 
patient's aorta. (Courtesy of Edwards Lifcsciences SAS.) 
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Full root replacement technique: Trinuning anti proximal 
stiture line. Trimming tile bioprothcsis i done similar to the root 
inchision technique. For the proximal suture line, interrulited 
siiturcs of 2/0 niultifilalncnt or continuous utures of 3/0 mono- 
filament are placcd beginning at the connnissure lictwccn the left 
and right coronary sinuscs in a horizontal lllallc at the level of the 
native annuhls. I f  tile anmllus is calcified, then a strip of analo- 
gous licricardium ilia)" be incorporatcd into the suture line to aid 
hcmostasis. (Courtesy of Edwards Lifcsciences SAS.) 
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8 Coronary artery reimplantation and closure of tile aorta. Beginning 
with tlle left coronary artery, tile corollary buttons are sewn into tlle 
buttonholes that were nmde into the llrothesis earlier, using continuous 5/0 
nmnofilament suture. Care must be taken to not rotate, kink, or place 
tension on the coronary arteries. Then an end-to-end anastomosis with 4/0 
monofilaluent suture is done to attach the bioprosthesis to the llaticnt's 
ascending aorta. The distal anastomosis often requires gathering or trim- 
ruing the aorta, llecause tile native aorta is sometimes larger at the distal 
end, whereas the porcine aorta is tlle same size at both tile distal and 
proximal ends. The sltture line is started at the posterior side of the valve 
and then advanced forward around each side. (Courtesy of Edwards 
Lifeseiences SAS.) 
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Resul ts  
Patients requiring an isolated aortic .valve replacement 
lind a mortality rate of 3.4%. Those patients requiring 
aortic valve replacement and concomitant cardiac sur- 
gery had an early mortality rate of 6.7%. Causes of 
death included cardiac failure, multiorgan failure, 
bleeding, sepsis, respiratory failure, and gastrointesti- 
nal ischemia. Mortality was related to whether or not 
concomitant surgery lind to be performed. In this se- 
ries, the implantation technique lind no influence on 
mortality. 
Tllromboembolic events occurred in one patient as 
valve thrombosis requiring successful reoperation two 
years after the initial operation. Tiffs was related to a 
coagulation disorder. Reoperation because of valve de- 
generation was not necessary in this series. 
At discharge, the mean velocity (V mean) measured 
at the level of tlle aortic valve for different valve sizes 
ranged between 1.8 ln/s for the size 21 valve and 0.9 m/s 
for the size 29 valve. 7 Normal range is <1.5 m/s. In 
valve sizes 21 and 23, slightly elevated velocities were 
recorded, indicating a mild transvalvular gradient. In 
valves larger tllan size 25, normal hemodynamics ould 
be obtained irrespective of the operative technique 
used. Regurgitation >1 ~ occurred in 18 patients 
(4.3%), including four imtients with stentless valve en- 
docarditis. All four underwent successful reoperation, 
three of them again with a stentless valve. 
Discussion 
Tiffs series, with more tlmn 550 valve implants, shows 
tlmt stentless valves can be implanted with low mortal- 
ity and morbidity in patients requiring aortic valve 
replacement. We found no difference between subeoro- 
nary, root inclusion cylinder, and hdl root replacement 
in terms of morbidity, mortality, and llenlodynamics at 
discharge or later. 5 However, it is important o match 
tile teclmique of valve replacement to tile pathology of 
tlle patient's aortic valve and root. Currently, in cylin- 
drical aortic roots of diameter 25 mm or greater, we 
perform a subcoronary implantation. We use the root 
replacement teclmique in a narrow and also a very wide 
anulus, and in patients with aneurysms of the ascend- 
ing aorta. In patients with moderate amdoectasia nd 
wide but nonarieurysmal enlargement of the aortic root, 
the inclusion cylinder technique may be helpful. 6,7 
As with other replacement devices, concomitant sur- 
gery increases the risk of surgery, aHowever, mortality 
with and without concomitant surgery is in the range 
reported in other series and for other replacement 
devices. One nmst take into account that our patients 
constitute a nonselected cohort, because our general 
policy is to offer stentless valves to males over age 40 to 
45 and females over age 60 to 65. Data from Kirklin 9 
showed tlmt the degeneration of bioprosthetic valves is 
faster in youuger women titan in men and after meno- 
pause is the same level in women than in men. 
The versatility of the cylindrical stentless valve also 
allows implantation in difficult situations as true bicus- 
pid valves with the coronary orifices in the 180-degree 
position. They also can be used with the same ease as 
other replacement devices with nfinimally invasive 
techniques, l~ (Figure 9). Aneurysms of the ascending 
aorta can be treated effectively with a combination of 
total root replacement with tiffs tubular device and 
extension to the aortic arch with a Dacron prosthesis 
(Figure 10). In this situation, we prefer to use a gela- 
tine-coated Dacron graft. 
In our practice, the use of stentless valves has nearly 
totally eliminated the use of allografts for aortic valve 
9 Minimally invasive aortic valve replacement 
after J-shaped partial sternotomy. 
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l O Rep lacement  o f  the aort ic  root  with a 
P r ima P lus  stentless b ioprosthesis  and replace-  
merit of the ascending aor ta  with a Dacron  graft  for  
t reatntent  of a large anett rysm of the ascending 
aor ta  and aort ic  valve insuff ic iency. 
rcphtcement in adults. Younger aduhs are treated with 
mechanical valves or the Ross procedure. In this set- 
ting, a cylindrical stentless valve serves well for re- 
placement of the pulmonary valve.12 
This series underlines the good hemotlynanfic results 
that can be obtained with stentless valves. These ad- 
vantageotts hemodynamic resuhs are ntaintained over a 
period of at least six years. This sort of replacement 
device can be used in every aortic valve or root pathol- 
ogy, including acute native or prosthetic valve endo- 
carditis. The open question of the longevity of these 
replacement devices will be answered by ongoing stud- 
ies dttring the next three to five years. 
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